Blog Browse - Two Blokes Trading

Posted Apr 4 by Two Blokes

UBS reaffirmed its Buy rating on Johnson & Johnson (NYSE:JNJ) and maintained a $180 price target, but highligh

Posted Apr 4 by Two Blokes

UBS maintained a Buy rating on Neurocrine Biosciences (NASDAQ:NBIX) but reduced its price target to $137 from

Posted Apr 4 by Two Blokes

Lindsay Corporation (NYSE:LNN), a key player in the manufacturing sector, particularly in farm equipment, has

Posted Apr 4 by Two Blokes

MSC Industrial Direct Co., Inc. (NYSE:MSM) reported an EPS of $0.72, surpassing the Zacks Consensus Estimate.

Posted Apr 4 by Two Blokes

Earnings Per Share (EPS) of $1.10, surpassing the Zacks Consensus Estimate by 26.44%. Revenue reached approxi

Posted Apr 4 by Two Blokes

Adverum Biotechnologies, Inc. (NASDAQ:ADVM) is under investigation by Pomerantz LLP for potential securities

Posted Apr 4 by Two Blokes

Guess?, Inc. (NYSE: GES) reported earnings per share of $1.48, beating estimates and showcasing strong market

Posted Apr 4 by Two Blokes

Lifecore Biomedical reported an EPS of -$0.47, missing the estimated EPS by a significant margin. The company

Posted Apr 4 by Two Blokes

Earnings per share of $0.963, beating the estimated $0.901. Revenue reached approximately $1.29 billion, surp

Posted Apr 4 by Two Blokes

Earnings Expectations: Analysts predict an EPS of $1.78 and revenue of approximately $898.5 million for Q2 fi

Posted Apr 4 by Two Blokes

Insight into APA Corporation's Recent Stock Purchase and Market Performance On April 3, 2025, Joung Chansoo

Posted Apr 3 by Two Blokes

NVIDIA (NASDAQ:NVDA) saw its rating lowered from Buy to Hold by HSBC analysts, who also reduced the price targ